ClinicalTrials.govpublic full text
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC
prostatic neoplasms, genital neoplasms, male, urogenital neoplasms, prostate cancer, neoplasms by site, neoplasms, prostatic disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855765
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.